TRT on TikTok: separating real talk from hormone hype

What did @johnnytuparelli actually say?

The creator pushed back hard against the idea that 60mg/week of testosterone is automatically too low for someone starting TRT. His core argument: "it affects everybody different just like any other medication." He also made a point worth repeating, that TRT exists "to alleviate symptoms," not to produce a physique. He shared his own protocol, 70mg/week split into 35mg twice weekly, which keeps his total testosterone between 700 and 750 ng/dL with no reported side effects. His advice to the viewer: trust your doctor, be honest with them, and ignore friends who treat testosterone like a gym supplement.

This is a response video, so the context matters. The viewer's friends, presumably on higher doses from TRT clinics, were essentially telling him his doctor underdosed him before he even took his first injection. The creator's reaction to that is the main thing worth fact-checking.

Does the science back this up?

Yes, more than most TRT content on this platform. Individual variability in testosterone pharmacokinetics is well-documented, and the idea that a single dose fits everyone is not supported by the literature.

A 2017 study by Bhasin et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that the testosterone dose-response relationship varies substantially between men, particularly for sexual function and mood outcomes. Two men on identical doses can land at very different serum levels depending on body composition, SHBG levels, and metabolic clearance rate. A 60mg/week protocol is on the lower end but is not outside clinical norms, especially as a starting point. The Endocrine Society's 2018 clinical practice guidelines recommend titrating to mid-normal physiological range, which can often be achieved at conservative doses. Starting low and adjusting based on labs and symptom response is actually the more responsible clinical approach. His own example supports this: 70mg/week producing levels around 700-750 ng/dL sits comfortably within a physiological range that many guidelines target.

What did they get right and what did they miss?

He got the big things right. Dose individualization is real, symptom relief is the legitimate goal of TRT in hypogonadal men, and letting gym friends drive your medical decisions is genuinely bad advice.

Where things get a little fuzzy: the creator presents his own anecdotal protocol as implicit evidence that lower doses work better. That may be true for him, but it carries the same logical flaw he criticizes his friends for: one person's response does not generalize. He also frames feeling "the best" as the primary metric, which, while understandable, is not the same as clinical endpoints like bone density, cardiovascular markers, or verified symptom resolution on validated tools like the AMS or ADAM questionnaire.

He does not mention labs beyond total and free testosterone, which leaves out SHBG, hematocrit, estradiol, and PSA. These are not optional monitors on TRT. A Hackett et al. 2016 review in Therapeutic Advances in Urology emphasized that TRT safety monitoring requires tracking multiple biomarkers, not just testosterone levels.

What should you actually know?

If you are starting TRT, 60mg/week is a clinically reasonable starting dose. It is not a sign your doctor is undertreating you. Starting conservatively and titrating based on follow-up labs and symptom response is standard practice, and it reduces the risk of erythrocytosis and other dose-dependent side effects.

The creator is also correct that TRT clinics have a financial incentive to prescribe higher doses, and some research supports this concern. A 2020 analysis by Baillargeon et al. in JAMA Internal Medicine found that testosterone prescribing patterns varied widely and were not always driven by clinical indication. Clinics competing for patients sometimes optimize for how people feel in the short term at the cost of longer-term safety monitoring.

The friends-know-best problem is real. Anecdotal dose comparisons in social groups drive a lot of unsupervised dose escalation. If you want to change your dose, that conversation belongs with your prescribing physician, supported by labs, not a group chat.